Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXF31R
|
||||
Drug Name |
2-[2-(Morpholine-4-sulfonylamino)-3-phenyl-propionylamino]-pent-4-enoic acid (1-cyclohexylmethyl-4-[1,3]dithian-2-yl-2,4-dihydroxy-butyl)-amide
|
||||
Synonyms |
CHEMBL87025
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C33H52N4O7S3
|
||||
Canonical SMILES |
O[C@@H](C[C@H](O)C1SCCCS1)[C@H](CC2CCCCC2)NC(=O)[C@H](CC=C)NC(=O)[C@H](Cc3ccccc3)NS(=O)(=O)N4CCOCC4
|
||||
InChI |
InChI=1S/C33H52N4O7S3/c1-2-10-26(34-32(41)28(22-25-13-7-4-8-14-25)36-47(42,43)37-15-17-44-18-16-37)31(40)35-27(21-24-11-5-3-6-12-24)29(38)23-30(39)33-45-19-9-20-46-33/h2,4,7-8,13-14,24,26-30,33,36,38-39H,1,3,5-6,9-12,15-23H2,(H,34,41)(H,35,40)/t26-,27-,28-,29-,30-/m0/s1
|
||||
InChIKey |
ZKQFFTQZNAYNHR-IIZANFQQSA-N
|
||||
Target and Pathway | |||||
Target(s) | Renin, renal | Target Info | [1587926] | ||
Cathepsin D | Target Info | [1587926] | |||
BioCyc Pathway | Thyroid hormone biosynthesis | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | LKB1 signaling events | ||||
Ceramide signaling pathway | |||||
Direct p53 effectors | |||||
Validated nuclear estrogen receptor alpha network | |||||
PathWhiz Pathway | Angiotensin Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.